D. Altieri, New wirings in the survivin networks, Oncogene, vol.113, issue.48, pp.6276-6284, 2008.
DOI : 10.1016/S0092-8674(02)01250-3

S. Ruchaud, M. Carmena, and W. Earnshaw, Chromosomal passengers: conducting cell division, Nature Reviews Molecular Cell Biology, vol.117, issue.10, pp.798-812, 2007.
DOI : 10.1038/nrm2257

S. Lens, R. Wolthuis, R. Klompmaker, J. Kauw, R. Agami et al., Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension, The EMBO Journal, vol.22, issue.12, pp.2934-2947, 2003.
DOI : 10.1093/emboj/cdg307

T. Dohi, F. Xia, and D. Altieri, Compartmentalized Phosphorylation of IAP by Protein Kinase A Regulates Cytoprotection, Molecular Cell, vol.27, issue.1, pp.17-28, 2007.
DOI : 10.1016/j.molcel.2007.06.004

Z. Song, X. Yao, and M. Wu, Direct Interaction between Survivin and Smac/DIABLO Is Essential for the Anti-apoptotic Activity of Survivin during Taxol-induced Apoptosis, Journal of Biological Chemistry, vol.278, issue.25, pp.23130-23140, 2003.
DOI : 10.1074/jbc.M300957200

D. Altieri, Survivin, cancer networks and pathway-directed drug discovery, Nature Reviews Cancer, vol.65, issue.1, pp.61-70, 2008.
DOI : 10.1038/ni1413

D. Brennan, E. Rexhepaj, O. Brien, S. Mcsherry, E. et al., Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast Cancer, Clinical Cancer Research, vol.14, issue.9, pp.2681-2689, 2008.
DOI : 10.1158/1078-0432.CCR-07-1760

S. Paik, S. Shak, G. Tang, C. Kim, J. Baker et al., A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer, New England Journal of Medicine, vol.351, issue.27, pp.2817-2826, 2004.
DOI : 10.1056/NEJMoa041588

P. Jézéquel, D. Loussouarn, C. Guérin-charbonnel, L. Campion, A. Vanier et al., Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response, Breast Cancer Research, vol.9, issue.1, p.43, 2015.
DOI : 10.1371/journal.pone.0095224

C. Lee, C. Raskett, I. Prudovsky, and D. Altieri, Molecular Dependence of Estrogen Receptor-Negative Breast Cancer on a Notch-Survivin Signaling Axis, Cancer Research, vol.68, issue.13, pp.5273-5281, 2008.
DOI : 10.1158/0008-5472.CAN-07-6673

R. Wang, Y. Zheng, H. Kim, X. Xu, L. Cao et al., Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis, ) Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis, pp.11-20, 2008.
DOI : 10.1016/j.molcel.2008.09.011

A. Chakravarti, G. Zhai, M. Zhang, R. Malhotra, D. Latham et al., Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms, Oncogene, vol.23, issue.45, pp.7494-7506, 2004.
DOI : 10.1038/sj.onc.1208049

J. Lu, M. Tan, W. Huang, P. Li, H. Guo et al., Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance, Clinical Cancer Research, vol.15, issue.4, pp.1326-1334, 2009.
DOI : 10.1158/1078-0432.CCR-08-0954

W. Bonner, C. Redon, J. Dickey, A. Nakamura, O. Sedelnikova et al., ??H2AX and cancer, Nature Reviews Cancer, vol.69, issue.12, pp.957-967, 2008.
DOI : 10.1158/0008-5472.CAN-05-4275

L. Krejci, V. Altmannova, M. Spirek, and X. Zhao, Homologous recombination and its regulation, Nucleic Acids Research, vol.40, issue.13, pp.5795-5818, 2012.
DOI : 10.1093/nar/gks270

G. Jiang, B. Ren, L. Xu, S. Song, C. Zhu et al., Survivin may enhance DNA double-strand break repair capability by up-regulating Ku70 in human KB cells, Anticancer Res, vol.29, pp.223-228, 2009.

S. Reichert, C. Rödel, J. Mirsch, P. Harter, M. Tomicic et al., Survivin inhibition and DNA double-strand break repair: A molecular mechanism to overcome radioresistance in glioblastoma, Radiotherapy and Oncology, vol.101, issue.1, pp.51-58, 2011.
DOI : 10.1016/j.radonc.2011.06.037

N. Turner, A. Tutt, and A. Ashworth, Opinion: Hallmarks of 'BRCAness' in sporadic cancers, Nature Reviews Cancer, vol.56, issue.10, pp.814-819, 2004.
DOI : 10.1093/jnci/90.15.1138

N. Bah, L. Maillet, J. Ryan, S. Dubreil, F. Gautier et al., Bcl-xL controls a switch between cell death modes during mitotic arrest, Cell Death and Disease, vol.21, issue.6, p.1291
DOI : 10.1016/j.ejmech.2012.02.036

G. Nelson, M. Buhmann, and T. Von-zglinicki, DNA damage foci in mitosis are devoid of 53BP1, Cell Cycle, vol.8, issue.20, pp.3379-3383, 2009.
DOI : 10.4161/cc.8.20.9857

C. Laulier, A. Barascu, J. Guirouilh-barbat, G. Pennarun, L. Chalony et al., Bcl-2 Inhibits Nuclear Homologous Recombination by Localizing BRCA1 to the Endomembranes, Cancer Research, vol.71, issue.10, pp.3590-3602, 2011.
DOI : 10.1158/0008-5472.CAN-10-3119

URL : https://hal.archives-ouvertes.fr/hal-00720358

S. Supiot, S. Gouard, J. Charrier, C. Apostolidis, J. Chatal et al., Mechanisms of Cell Sensitization to ?? Radioimmunotherapy by Doxorubicin or Paclitaxel in Multiple Myeloma Cell Lines, Clinical Cancer Research, vol.11, issue.19, pp.7047-7052, 2005.
DOI : 10.1158/1078-0432.CCR-1004-0021

P. Jézéquel, J. Frénel, L. Campion, C. Guérin-charbonnel, W. Gouraud et al., Campone M (2013) bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses, Database, p.60

P. Jézéquel, M. Campone, W. Gouraud, C. Charbonnel, C. Leux et al., bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer, Breast Cancer Research and Treatment, vol.11, issue.Database Issue, pp.765-775
DOI : 10.1007/s10549-011-1457-7

R. Paulsen, D. Soni, R. Wollman, A. Hahn, M. Yee et al., A Genome-wide siRNA Screen Reveals Diverse Cellular Processes and Pathways that Mediate Genome Stability, Molecular Cell, vol.35, issue.2, pp.228-239, 2009.
DOI : 10.1016/j.molcel.2009.06.021

S. Minocherhomji and I. Hickson, Structure-specific endonucleases: guardians of fragile site stability, Trends in Cell Biology, vol.24, issue.5, pp.321-327, 2014.
DOI : 10.1016/j.tcb.2013.11.007

N. Laguette, C. Brégnard, P. Hue, J. Basbous, A. Yatim et al., Premature Activation of the SLX4 Complex by Vpr Promotes G2/M Arrest and Escape from Innate Immune Sensing, Cell, vol.156, issue.1-2, pp.134-145, 2014.
DOI : 10.1016/j.cell.2013.12.011

URL : https://hal.archives-ouvertes.fr/hal-00957510

V. Naim, T. Wilhelm, M. Debatisse, and F. Rosselli, ERCC1 and MUS81???EME1 promote sister chromatid separation by processing late replication intermediates at common fragile sites during mitosis, Nature Cell Biology, vol.277, issue.8, pp.1008-1015, 2013.
DOI : 10.1038/ncb2793

M. Kostrouchova, Z. Kostrouch, V. Saudek, J. Piatigorsky, and J. Rall, BIR-1, a Caenorhabditis elegans homologue of Survivin, regulates transcription and development, Proceedings of the National Academy of Sciences, vol.100, issue.9, pp.5240-5245, 2003.
DOI : 10.1073/pnas.0730770100

F. Wang, J. Dai, J. Daum, E. Niedzialkowska, B. Banerjee et al., Histone H3 Thr-3 Phosphorylation by Haspin Positions Aurora B at Centromeres in Mitosis, Science, vol.330, issue.6001, pp.231-235, 2010.
DOI : 10.1126/science.1189435

L. Tang, X. Ling, W. Liu, G. Das, and F. Li, Transcriptional inhibition of p21WAF1/CIP1 gene (CDKN1) expression by survivin is at least partially p53-dependent: Evidence for survivin acting as a transcription factor or co-factor, Biochemical and Biophysical Research Communications, vol.421, issue.2, pp.249-254, 2012.
DOI : 10.1016/j.bbrc.2012.03.147

Y. Li, X. Ma, X. Wu, X. Liu, and L. Liu, Prognostic Significance of Survivin in Breast Cancer: Meta-analysis, The Breast Journal, vol.14, issue.5, pp.514-524, 2014.
DOI : 10.1111/tbj.12303

A. Faversani, V. Vaira, G. Moro, D. Tosi, A. Lopergolo et al., Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors, Breast Cancer Research, vol.24, issue.3, p.55, 2014.
DOI : 10.1093/annonc/mdt249

Y. Hu, K. Xu, and E. Yagüe, miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer, Breast Cancer Research and Treatment, vol.18, issue.6, pp.269-280, 2015.
DOI : 10.1007/s10549-015-3372-9

C. Rödel, J. Haas, A. Groth, G. Grabenbauer, R. Sauer et al., Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: Survivin as a radioresistance factor, International Journal of Radiation Oncology*Biology*Physics, vol.55, issue.5, pp.1341-1347, 2003.
DOI : 10.1016/S0360-3016(02)04618-7

B. Lu, Y. Mu, C. Cao, F. Zeng, S. Schneider et al., Survivin As a Therapeutic Target for Radiation Sensitization in Lung Cancer, Cancer Research, vol.64, issue.8, pp.2840-2845, 2004.
DOI : 10.1158/0008-5472.CAN-03-3547

A. Rauch, D. Hennig, C. Schäfer, M. Wirth, C. Marx et al., Survivin and YM155: How faithful is the liaison?, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1845, issue.2, pp.202-220, 2014.
DOI : 10.1016/j.bbcan.2014.01.003

X. Ling, S. Cao, Q. Cheng, J. Keefe, Y. Rustum et al., A Novel Small Molecule FL118 That Selectively Inhibits Survivin, Mcl-1, XIAP and cIAP2 in a p53-Independent Manner, Shows Superior Antitumor Activity, PLoS ONE, vol.7, issue.9, p.45571, 2012.
DOI : 10.1371/journal.pone.0045571.t002

T. Iwasa, I. Okamoto, M. Suzuki, T. Nakahara, K. Yamanaka et al., Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell Lines, Clinical Cancer Research, vol.14, issue.20, pp.6496-6504, 2008.
DOI : 10.1158/1078-0432.CCR-08-0468

E. Véquaud, C. Séveno, D. Loussouarn, L. Engelhart, M. Campone et al., YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-kB network, Oncotarget, vol.6, issue.15, pp.13476-13486
DOI : 10.18632/oncotarget.3638